AbbVie Stock Still a Solid Buy Despite Challenges Hosted by Laycee KluinFebruary 27, 2023 ShareLink copied to clipboard. Play video for AbbVie Stock Still a Solid Buy Despite ChallengesDetailsGuestsIn this video, Chris and Laycee discuss AbbVie's mixed earnings report in early February and why the stock has struggled to find momentum. They also touch on AbbVie's pipeline and the impact of Humira's patent expiration. Chris highlights the company's status as a Dividend King and why it could be a good investment option for investors.Read The Stock That Tripled in a Day...And May Not Be DoneStocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioABBVAbbVie4.9773 of 5 stars$175.54+0.2%3.74%60.95 Add This Stock to My Watchlist Chris Markoch, GuestMarketBeat Contributor, MarketBeatChris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | Sponsored13 Stocks With Strong Institutional BuyingHedge funds, university endowments, pension funds, and sovereign wealth funds have been pouring money into an ...MarketBeatAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | Sponsored7 Stocks to Ride the Autonomous Driving BoomThe global autonomous vehicle (AV) market is growing. According to the Autonomous Vehicle Industry Association...MarketBeatHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored7 Growth Stocks Positioned for Further Growth In 2023 and 2024, the stock market outperformed analyst expectations, with the S&P 500 index gaining ove...MarketBeat Listen to MarketBeat Other Platforms Recent Videos Featured Articles and OffersSizing Up a New Opportunity for NVIDIA InvestorsJanuary 27, 2025View Sizing Up a New Opportunity for NVIDIA InvestorsBetter than Bitcoin – and potentially more profitableFrom Brownstone Research(Ad)View Better than Bitcoin – and potentially more profitable3 Buy-and-Hold Stocks for Long-Term GrowthJanuary 24, 2025View 3 Buy-and-Hold Stocks for Long-Term GrowthWhy Energy Transfer Stock Could Soar to New Highs in 2025January 24, 2025View Why Energy Transfer Stock Could Soar to New Highs in 2025Got 1K to Invest? These 3 Stocks Are Still Magnificent BuysJanuary 24, 2025View Got 1K to Invest? These 3 Stocks Are Still Magnificent BuysThis Crypto Is Set to Explode in JanuaryFrom Crypto 101 Media(Ad)View This Crypto Is Set to Explode in January Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hosted by Laycee KluinFebruary 27, 2023 ShareLink copied to clipboard. Play video for AbbVie Stock Still a Solid Buy Despite ChallengesDetailsGuestsIn this video, Chris and Laycee discuss AbbVie's mixed earnings report in early February and why the stock has struggled to find momentum. They also touch on AbbVie's pipeline and the impact of Humira's patent expiration. Chris highlights the company's status as a Dividend King and why it could be a good investment option for investors.Read The Stock That Tripled in a Day...And May Not Be DoneStocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioABBVAbbVie4.9773 of 5 stars$175.54+0.2%3.74%60.95 Add This Stock to My Watchlist Chris Markoch, GuestMarketBeat Contributor, MarketBeatChris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | Sponsored13 Stocks With Strong Institutional BuyingHedge funds, university endowments, pension funds, and sovereign wealth funds have been pouring money into an ...MarketBeatAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | Sponsored7 Stocks to Ride the Autonomous Driving BoomThe global autonomous vehicle (AV) market is growing. According to the Autonomous Vehicle Industry Association...MarketBeatHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored7 Growth Stocks Positioned for Further Growth In 2023 and 2024, the stock market outperformed analyst expectations, with the S&P 500 index gaining ove...MarketBeat
